GLOBAL BLOOD THERAPEUTICS IN

Historical 13F Holders

CUSIP
37890U108
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1 1.00 $68.00
2024 Q4 1 1.00 $68.00
2024 Q3 1 1.00 $68.00
2024 Q2 1 1.00 $68.00
2024 Q1 1 1.00 $68.00
2023 Q4 1 1.00 $68.00
2023 Q3 1 1.00 $68.00
2023 Q2 1 1.00 $68.00
2023 Q1 1 1.00 $68.00
2022 Q4 2 622 $42.1 k
2022 Q3 276 69.8 M $4.75 B
2022 Q2 205 71.7 M $2.29 B
2022 Q1 221 70.7 M $2.44 B
2021 Q4 229 69.0 M $2.02 B
2021 Q3 206 60.7 M $1.55 B
2021 Q2 218 69.3 M $2.43 B
2021 Q1 235 71.5 M $2.91 B
2020 Q4 269 64.9 M $2.83 B
2020 Q3 257 64.2 M $3.54 B
2020 Q2 283 64.8 M $4.10 B
2020 Q1 249 65.1 M $3.33 B
2019 Q4 270 60.4 M $4.80 B
2019 Q3 243 60.8 M $2.95 B
2019 Q2 267 59.9 M $3.15 B
2019 Q1 235 58.1 M $3.07 B
2018 Q4 226 57.5 M $2.36 B
2018 Q3 216 53.9 M $2.05 B
2018 Q2 240 51.8 M $2.35 B
2018 Q1 200 50.5 M $2.44 B
2017 Q4 179 43.4 M $1.71 B
2017 Q3 148 39.6 M $1.23 B
2017 Q2 152 37.6 M $1.03 B
2017 Q1 134 31.7 M $1.17 B
2016 Q4 106 25.6 M $371 M
2016 Q3 92 21.3 M $490 M
2016 Q2 98 23.4 M $389 M
2016 Q1 80 14.5 M $230 M
2015 Q4 69 14.7 M $470 M
2015 Q3 60 27.5 M $1.16 B